Mercia Pharma Inc., has established a portfolio of unique products to prevent and treat diseases which afflict millions of people worldwide. Based on its clinically proven immunotherapeutic technology, MERIT, the Company has therapeutic and prophylactic vaccines in development for three broad disease categories: MERIT promises to deliver novel and effective therapies addressing the unmet medical needs of a number of serious medical conditions.
View Top Employees from MERCIA PHARMA, INC.Website | http://www.merciapharma.com/ |
Revenue | $4 million |
Employees | 3 (2 on RocketReach) |
Address | 111 Brewster Rd, Scarsdale, New York 10583, US |
Phone | (212) 265-6098 |
Technologies |
JavaScript,
HTML,
PHP
+2 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
Competitors | Immunohelix, Novoclinica Inc, The IUPHAR/BPS Guide to PHARMACOLOGY |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular MERCIA PHARMA, INC. employee's phone or email?
The MERCIA PHARMA, INC. annual revenue was $4 million in 2024.
Peter Blackburn is the President of MERCIA PHARMA, INC..
2 people are employed at MERCIA PHARMA, INC..
MERCIA PHARMA, INC. is based in Scarsdale, New York.
The NAICS codes for MERCIA PHARMA, INC. are [32541, 32, 3254, 325].
The SIC codes for MERCIA PHARMA, INC. are [28, 283].